Creative Planning

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1540235 OVERLAND PARK, KS

Position in AUPH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$885,103

+$312,399 QoQ

Shares Held

52,157

+35.0% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#107

of 279 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. AUPH ranks #90 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$885,103	52,157	+35.0%	Shares	Defined	2026-08-13
2026-03-31	$572,704	38,644	+55.6%	Shares	Sole	2026-05-12
2025-12-31	$396,229	24,842	-3.2%	Shares	Sole	2026-02-17
2025-09-30	$283,653	25,670	+24.0%	Shares	Defined	2025-11-14
2025-06-30	$175,320	20,699	+21.0%	Shares	Defined	2025-08-08
2025-03-31	$137,524	17,105	+6.0%	Shares	Sole	2025-05-15
2024-12-31	$144,865	16,132	+9.9%	Shares	Sole	2025-02-14
2024-09-30	$107,611	14,681	-4.3%	Shares	Sole	2024-10-11
2024-06-30	$87,619	15,345	+34.8%	Shares	Sole	2024-08-15
2023-12-31	$102,342	11,384	-82.2%	Shares	Sole	2024-02-14
2021-03-31	$832,728	64,130	+4.9%	Shares	Sole	2021-04-30
2020-12-31	$845,497	61,135	-15.6%	Shares	Sole	2021-01-29
2020-09-30	$1,066,746	72,420	+6.2%	Shares	Sole	2020-11-05
2020-06-30	$1,108,250	68,200	-0.4%	Shares	Sole	2020-07-23
2020-03-31	$993,935	68,500	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.